pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis

PHARMACEUTICALS - NAMELY, ANTICANCER AGENTS AND PHARMACEUTICALS FOR THE TREATMENT OF VASCULAR DISORDERS